Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

People with polycystic ovary syndrome have worse meibomian gland and ocular surface conditions.

Bicalutamide may help treat female pattern hair loss.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

More research is needed to understand how testosterone is maintained in adult males.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

New understanding of hair loss could lead to better treatments.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Research on Hutchinson-Gilford progeria syndrome could help understand normal aging and heart disease.

Hutchinson-Gilford Progeria Syndrome causes rapid aging from a genetic mutation, with no cure but ongoing research into potential treatments.

Progeria, a disease that causes early aging, is linked to a gene mutation and helps us understand normal aging.